AHA	Active and Healthy Ageing
CRSwNP	Chronic rhinosinusitis with nasal polyps
EGPA	Eosinophilic granulomatosis with polyangiitis
EIP	European Innovation Partnership
FEV1	Forced expiratory volume in the first second
FVC	Forced vital capacity
GINA	Global Initiative for Asthma
ICPs	Integrated Care Pathways
ICS	Inhaled corticosteroids
LABA	Long-acting beta-agonist
LAMA	Long-acting muscarinic agonist
MASK	Mobile Airways Sentinel NetworK
mMPR	modified medication possession ratio
OSAS	Obstructive Sleep Apnea Syndrome
PRO	patient-reported outcome
SIgE	Serum specific IgE
VAS	visual analogue scales